Hepatitis C infection and disease

丙型肝炎感染和疾病

• 批准号: nhmrc : GNT1053206
• 负责人: A/Pr Michael Beard
• 金额: $ 542.79万
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/hepatitis-c-infection-disease/1344540
• 关键词: Hepatitis; infection; disease

Hepatitis C affects a quarter of a million Australians, causing insidious but progressive liver disease which culminates in liver failure or cancer. There is no vaccine and prevention programs have limited effectiveness, but new antiviral therapies now offer high rates of cure. This Program will evaluate strategies to improve the health of those affected and prevent new infections by better understanding of the virus and the body’s immune response, including scarring and liver cancer formation.

丙型肝炎影响着25万澳大利亚人，它会导致潜伏但渐进的肝脏疾病，最终导致肝功能衰竭或癌症。目前还没有疫苗，预防计划的效果有限，但新的抗病毒疗法现在提供了很高的治愈率。该方案将通过更好地了解病毒和人体免疫反应（包括疤痕和肝癌的形成）来评估改善受感染者健康和预防新感染的战略。